EP 1146904 A4 20040915 - USE OF HYDROXYUREA AND A REVERSE TRANSCRIPTASE INHIBITOR TO INDUCE AUTOVACCINATION BY AUTOLOGOUS HIV
Title (en)
USE OF HYDROXYUREA AND A REVERSE TRANSCRIPTASE INHIBITOR TO INDUCE AUTOVACCINATION BY AUTOLOGOUS HIV
Title (de)
VERWENDUNG VON HYDROXYHARNSTOFF UND EINEM HEMMSTOFF DER REVERSEN TRANSKRIPTASE ZUR INDUKTION EINER AUTOVAKZINATION DURCH AUTOLOGES HIV
Title (fr)
UTILISATION D'HYDROXYUREE ET D'UN INHIBITEUR DE LA TRANSCRIPTASE INVERSE POUR INDUIRE UNE AUTOVACCINATION PAR UN VIH AUTOLOGUE
Publication
Application
Priority
- US 0002754 W 20000202
- US 24375399 A 19990203
- US 49376900 A 20000128
Abstract (en)
[origin: WO0045844A1] A method for inducing autovaccination by autologous human immunodeficiency virus is disclosed comprising the step of administering to said cells a combination of compounds selected from the group consisting of hydroxyurea, a nucleoside analog, and, optionally, a protease inhibitor, and further comprising the steps of stopping treatment and restarting treatment under controlled conditions.
IPC 1-7
A61K 39/42; A61K 39/00; A61K 39/21; A61K 39/29; A61K 39/12; A61K 39/13; A61K 31/70
IPC 8 full level
A61K 39/21 (2006.01); A61K 45/06 (2006.01); A61P 31/18 (2006.01)
CPC (source: EP)
A61K 39/12 (2013.01); A61K 39/21 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2017.12); A61K 2039/545 (2013.01); C12N 2740/15034 (2013.01)
Citation (search report)
- [X] WO 9622777 A1 19960801 - AGUETTANT LAB [FR]
- [X] WO 9427590 A1 19941208 - US GOV HEALTH & HUMAN SERV [US]
- See references of WO 0045844A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0045844 A1 20000810; AU 2753700 A 20000825; EP 1146904 A1 20011024; EP 1146904 A4 20040915
DOCDB simple family (application)
US 0002754 W 20000202; AU 2753700 A 20000202; EP 00905949 A 20000202